Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

18.2%

2 terminated/withdrawn out of 11 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
5(45.5%)
Early Phase 1
2(18.2%)
Phase 2
1(9.1%)
Phase 3
1(9.1%)
Phase 4
1(9.1%)
Phase 1
1(9.1%)
11Total
N/A(5)
Early Phase 1(2)
Phase 2(1)
Phase 3(1)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)